Postnatal BDNF expression profiles in prefrontal cortex and hippocampus of a rat schizophrenia model induced by MK-801 administration

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Si, Tianmei ^a   Guo, Chunmei ^a   Yang, Yang ^a   Su, Yun'ai ^a  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DIZOCILPINE; DIZOCILPINE MALEATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; LOCOMOTION; NONHUMAN; OPEN FIELD TEST; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA; ANIMAL; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION PROFILING; METABOLISM; MOTOR ACTIVITY; NEWBORN; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; ANIMALS, NEWBORN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; FEMALE; GENE EXPRESSION PROFILING; HIPPOCAMPUS; MOTOR ACTIVITY; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA;

EID: 77955369320     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/783297     Document Type: Article

References (34)

1. Weinberger D. R., On the plausibility of the neurodevelopmental hypothesis of schizophrenia Proceedings of the Symposium on a New Understanding: Neurological Basis and Long-Term Outcome of Schizophrenia, at the CINP Congress 1994 Washington, DC, USA Elsevier Science
2. Rehn A. E., Rees S. M., Investigating the neurodevelopmental hypothesis of schizophrenia Clinical and Experimental Pharmacology and Physiology 2005 32 9 687 696
3. Pearce B. D., Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms Molecular Psychiatry 2001 6 6 634 646
4. Cannon M., Jones P. B., Murray R. M., Obstetric complications and schizophrenia: historical and meta-analytic review American Journal of Psychiatry 2002 159 7 1080 1092
5. Weickert C. S., Weinberger D. R., A candidate molecule approach to defining developmental pathology in schizophrenia Schizophrenia Bulletin 1998 24 2 303 316
6. Ernfors P., Wetmore C., Olson L., Persson H., Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family Neuron 1990 5 4 511 526
7. Hofer M., Pagliusi S. R., Hohn A., Leibrock J., Barde Y.-A., Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain EMBO Journal 1990 9 8 2459 2464
8. Huang E. J., Reichardt L. F., Neurotrophins: roles in neuronal development and function Annual Review of Neuroscience 2001 24 677 736
9. Lewin G. R., Barde Y.-A., Physiology of the neurotrophins Annual Review of Neuroscience 1996 19 289 317
10. Lu B., BDNF and activity-dependent synaptic modulation Learning and Memory 2003 10 2 86 98
11. McAllister A. K., Subplate neurons: a missing link among neurotrophins, activity, and ocular dominance plasticity? Proceedings of the National Academy of Sciences of the United States of America 1999 96 24 13600 13602
12. Poo M.-M., Neurotrophins as synaptic modulators Nature Reviews Neuroscience 2001 2 1 24 32
13. Durany N., Michel T., Zchling R., Boissl K. W., Cruz-Snchez F. F., Riederer P., Thome J., Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses Schizophrenia Research 2001 52 1-2 79 86
14. Shoval G., Weizman A., The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia European Neuropsychopharmacology 2005 15 3 319 329
15. Weickert C. S., Hyde T. M., Lipska B. K., Herman M. M., Weinberger D. R., Kleinman J. E., Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia Molecular Psychiatry 2003 8 6 592 610
16. Wiseman Harris L., Sharp T., Gartlon J., Jones D. N. C., Harrison P. J., Long-temperm behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism European Journal of Neuroscience 2003 18 6 1706 1710
17. Adams B., Moghaddam B., Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine Journal of Neuroscience 1998 18 14 5545 5554
18. Steinpreis R. E., Sokolowski J. D., Papanikolaou A., Salamone J. D., The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat Pharmacology Biochemistry and Behavior 1994 47 3 579 585
19. Wolf M. E., The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants Progress in Neurobiology 1998 54 6 679 720
20. Su Y.-A., Si T.-M., Zhou D.-F., Guo C.-M., Wang X.-D., Yang Y., Shu L., Liang J.-H., Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT2A/2C receptors European Journal of Pharmacology 2007 564 13 123 130
21. Spear L. P., The adolescent brain and age-related behavioral manifestations Neuroscience and Biobehavioral Reviews 2000 24 4 417 463
22. Webster M. J., Weickert C. S., Herman M. M., Kleinman J. E., BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex Developmental Brain Research 2002 139 2 139 150
23. Danielyan A., Nasrallah H. A., Neurological disorders in schizophrenia Psychiatric Clinics of North America 2009 32 4 719 757
24. van Os J., Kapur S., Schizophrenia The Lancet 2009 374 9690 635 645
25. Monteggia L. M., Luikart B., Barrot M., Theobold D., Malkovska I., Nef S., Parada L. F., Nestler E. J., Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors Biological Psychiatry 2007 61 2 187 197
26. Wang C., McInnis J., Ross-Sanchez M., Shinnick-Gallagher P., Wiley J. L., Johnson K. M., Long-temperm behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia Neuroscience 2001 107 4 535 550
27. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., Koizumi S., Wakabayashi K., Takahashi H., Someya T., Nawa H., Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients Molecular Psychiatry 2000 5 3 293 300
28. Kang H., Schuman E. M., Long-lasting neuratrophin-induced enhancement of synaptic transmission in the adult hippocampus Science 1995 267 5204 1658 1662
29. Takahashi M., Kakita A., Futamura T., Watanabe Y., Mizuno M., Sakimura K., Castren E., Nabeshima T., Someya T., Nawa H., Sustained brain-derived neurotrophic factor up-regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatment Journal of Neurochemistry 2006 99 3 770 780
30. Xia Y., Wang C. Z., Liu J., Anastasio N. C., Johnson K. M., Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways Neuropharmacology 2009 58 2 330 336
31. Jockers-Scherbl M. C., Danker-Hopfe H., Mahlberg R., Selig F., Rentzsch J., Schrer F., Lang U. E., Hellweg R., Brain-derived neurotrophic factor serum concentrations are increased in drug-nave schizophrenic patients with chronic cannabis abuse and multiple substance abuse Neuroscience Letters 2004 371 1 79 83
32. Pirildar S., Gnl A. S., Taneli F., Akdeniz F., Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004 28 4 709 713
33. Franklin T. B., Perrot-Sinal T. S., Sex and ovarian steroids modulate brain-derived neurotrophic factor (BDNF) protein levels in rat hippocampus under stressful and non-stressful conditions Psychoneuroendocrinology 2006 31 1 38 48
34. Wong J., Webster M. J., Cassano H., Weickert C. S., Changes in alternative brain-derived neurotrophic factor transcript expression in the developing human prefrontal cortex European Journal of Neuroscience 2009 29 7 1311 1322